The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127062811 12706281 1 I 200903 20090409 20160901 20160901 EXP US-ASTRAZENECA-2009BM04704 ASTRAZENECA 57.00 YR F Y 118.40000 KG 20160901 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127062811 12706281 1 PS BYETTA EXENATIDE 1 Subcutaneous U U A522932A 21773 5 UG SOLUTION FOR INJECTION IN PRE-FILLED PEN BID
127062811 12706281 2 SS BYETTA EXENATIDE 1 Subcutaneous U U A539392A 21773 10 UG SOLUTION FOR INJECTION IN PRE-FILLED PEN BID
127062811 12706281 3 SS BYETTA EXENATIDE 1 Subcutaneous U U 21773 SOLUTION FOR INJECTION IN PRE-FILLED PEN
127062811 12706281 4 SS CRESTOR ROSUVASTATIN CALCIUM 1 Oral Y U 0 TABLET
127062811 12706281 5 C EXENATIDE EXENATIDE 1 10UG 0 SOLUTION FOR INJECTION
127062811 12706281 6 C EXENATIDE EXENATIDE 1 5UG 0 SOLUTION FOR INJECTION
127062811 12706281 7 C ASA ASPIRIN 1 81.0MG UNKNOWN 0 81 MG
127062811 12706281 8 C MULTIVITAMIN VITAMINS 1 UNK 0
127062811 12706281 9 C ZITHROMAX AZITHROMYCIN DIHYDRATE 1 0
127062811 12706281 10 C PHENERGAN PROMETHAZINE HYDROCHLORIDE 1 UNK 0
127062811 12706281 11 C MORPHINE MORPHINE 1 UNK 0
127062811 12706281 12 C REGLAN METOCLOPRAMIDE HYDROCHLORIDE 1 Intravenous (not otherwise specified) UNK 0
127062811 12706281 13 C REGLAN METOCLOPRAMIDE HYDROCHLORIDE 1 Oral UNK 0
127062811 12706281 14 C PREVACID LANSOPRAZOLE 1 UNK 0
127062811 12706281 15 C PLAVIX CLOPIDOGREL BISULFATE 1 0
127062811 12706281 16 C TRULICITY DULAGLUTIDE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127062811 12706281 1 Type 2 diabetes mellitus
127062811 12706281 2 Type 2 diabetes mellitus
127062811 12706281 3 Type 2 diabetes mellitus
127062811 12706281 4 Blood cholesterol increased
127062811 12706281 9 Sinusitis
127062811 12706281 10 Nausea
127062811 12706281 11 Abdominal pain
127062811 12706281 12 Abdominal pain upper
127062811 12706281 13 Abdominal pain upper
127062811 12706281 14 Gastrooesophageal reflux disease

Outcome of event

Event ID CASEID OUTC COD
127062811 12706281 OT
127062811 12706281 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
127062811 12706281 Chest pain
127062811 12706281 Glycosylated haemoglobin increased
127062811 12706281 Myocardial infarction
127062811 12706281 Pancreatitis
127062811 12706281 Reflux gastritis
127062811 12706281 Sinusitis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127062811 12706281 1 200902 200903 0
127062811 12706281 2 200903 0
127062811 12706281 3 20160822 0
127062811 12706281 4 20151211 20160104 0
127062811 12706281 7 200903 0
127062811 12706281 8 200903 0
127062811 12706281 9 200903 2009 0
127062811 12706281 10 20090327 0
127062811 12706281 11 20090329 20090329 0
127062811 12706281 12 20090329 0
127062811 12706281 13 20090329 0
127062811 12706281 14 20090330 0